LOS ANGELES, April 18, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically ...
MORRISTOWN, N.J., March 4, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently ...
Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update
LOS ANGELES, May 8, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage, precision oncology company focused on developing and commercializing therapies for cancers with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback